Fact based stock research
Ophthotech (NasdaqGS:OPHT)


Ophthotech stock research in summary

ophthotech.com


Ophthotech shares have a BUY rating. They show above average growth, are good value and are safely financed. We recommend buying and holding Ophthotech shares.


Latest Obermatt Ranks


Country USA
Industry Biotechnology
Index NASDAQ
Size class X-Small

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Research History: Ophthotech

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
35
71
58
95
STOCK GROWTH RANKS
62
6
84
100
STOCK SAFETY RANKS
1
13
89
57
COMBINED STOCK RANKS
19
12
67
100

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Ophthotech in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Ophthotech; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
56
35
94
92
PROFIT GROWTH
17
13
13
100
STOCK RETURNS
78
1
20
33
CONSOLIDATED RANK: GROWTH
62
6
84
100

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Ophthotech.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
30
95
83
70
REFINANCING
41
1
1
14
LIQUIDITY
3
12
33
86
CONSOLIDATED RANK: SAFETY
1
13
89
57

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Ophthotech and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Ophthotech from June 8, 2018.